tiprankstipranks
Palisade Bio (PALI)
NASDAQ:PALI

Palisade Bio (PALI) Financial Statements

430 Followers

Palisade Bio Financial Overview

Palisade Bio's market cap is currently ―. The company's EPS TTM is $-2.924; its P/E ratio is -0.12; Palisade Bio is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue--$ 250.00K-$ 0.00
Gross Profit--$ 250.00K$ 1.90M-
EBIT$ -2.86M$ -3.39M$ -2.34M$ -3.72M$ -3.99M
EBITDA$ -2.86M$ -3.39M$ -2.34M$ -3.71M$ -3.99M
Net Income Common Stockholders$ -2.87M$ -3.39M$ -2.34M$ -11.93M$ -3.99M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 15.31M$ 16.40M$ 13.30M$ 12.38M$ 13.98M
Total Assets$ 17.07M$ 18.29M$ 15.25M$ 15.76M$ 16.27M
Total Debt$ 498.00K$ 677.00K$ 291.00K$ 404.00K$ 692.00K
Net Debt$ -14.81M$ -15.73M$ -13.01M$ -11.98M$ -13.29M
Total Liabilities$ 2.98M$ 2.49M$ 1.51M$ 3.28M$ 3.84M
Stockholders Equity$ 14.08M$ 15.80M$ 13.75M$ 12.48M$ 12.43M
Cash Flow-
Free Cash Flow$ -2.66M$ -2.20M$ -3.53M$ -3.32M$ -3.04M
Operating Cash Flow$ -2.66M$ -2.20M$ -3.53M$ -3.31M$ -3.04M
Investing Cash Flow-$ -4.00K-$ -10.00K$ 0.00
Financing Cash Flow$ 1.57M$ 5.31M$ 4.44M$ 1.71M$ 12.04M
Currency in USD

Palisade Bio Earnings and Revenue History

Palisade Bio Debt to Assets

Palisade Bio Cash Flow

Palisade Bio Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis